Gyre Therapeutics, Inc. GYRE Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s operating lease liabilities?
- Gyre Therapeutics, Inc. (GYRE) reported operating lease liabilities of $72K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Gyre Therapeutics, Inc.'s operating lease liabilities decreased by 90.8% year-over-year, from $780K to $72K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s operating lease liabilities has grown at a -20.9% compound annual growth rate (CAGR), from $981K to $303K.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.